Zero risk tolerance costs lives: loss of transplantable organs due to human immunodeficiency virus nucleic acid testing of potential donors.

Progress in transplantation (Aliso Viejo, Calif.)

Volumn 21, Issue 3, 2011, Pages

  Shafer, Teresa J ^a   Schkade, David ^b   Schkade, Lawrence ^b   Geier, Steven S ^b   Orlowski, Jeffrey P ^b   Klintmalm, Goran ^b  

^a LifeGift Organ Donation Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DISEASE TRANSMISSION; DONOR; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; RISK ASSESSMENT; SERODIAGNOSIS; TRANSPLANTATION; UNITED STATES;

AIDS SERODIAGNOSIS; COST-BENEFIT ANALYSIS; FALSE POSITIVE REACTIONS; HEALTH POLICY; HIV INFECTIONS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RISK ASSESSMENT; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; UNITED STATES;

MLCS; MLOWN;

EID: 84856390084     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.7182/prtr.21.3.w5068r3561qx56t6     Document Type: Article

References (0)